2RP-30481-59508
2 vaccinations
3 coded responses
26 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 756 / TX
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Arthralgia, Injection site pain, Joint range of motion decreased, Pain — Feeling: Good · Site: PainFree text: Shoulder soreness at the injection site is worse than yesterday and is slightly limiting ROM, but pain is not severe enough for me to say “moderate†painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-14
- 2021-01-21
-
2021-01-28
Dose 2 — Moderna
- 2021-01-28
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Mobility decreased — Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesFree text: Lost range of motion in shoulderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose abnormal, Type 1 diabetes mellitus — Feeling: Good · Site: PainFree text: I am Type I Diabetic. After yesterdays check-in, my blood sugar became extremely high (300+) for about 8 hours, despite giving more insulin. High blood sugar like that (though a bit lower than that) is typical when I am ill. A similar effect happened Day 2 after dose #1, though much less severe (in the low-200s) for a shorter time 4-5 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-04-29
- 2021-07-29
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Shoulder soreness at the injection site is worse than yesterday and is slightly limiting ROM, but pain is not severe enough for me to say “moderate†pain
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Lost range of motion in shoulder
Systemic reaction (other): I am Type I Diabetic. After yesterdays check-in, my blood sugar became extremely high (300+) for about 8 hours, despite giving more insulin. High blood sugar like that (though a bit lower than that) is typical when I am ill. A similar effect happened Day 2 after dose #1, though much less severe (in the low-200s) for a shorter time 4-5 hours.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Blood glucose abnormal | ✓ | ✓ | ✓ |
| SRO | Injected limb mobility decreased | ○ | ○ | ○ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Joint range of motion decreased | ✓ | ✓ | ✓ |
| SRO | Mobility decreased | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Type 1 diabetes mellitus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release